CAS Insights™

Accelerating your scientific progress by revealing unique connections and perspective at the intersection of science, technology, and innovation.

PRD1 bacteriophage, illustration. Molecular model of the structure of a PRD1 bacteriophage

Learn how to address PEG immunogenicity, a challenge that affects the safety and efficacy of PEGylated lipid nanoparticles for drug delivery. Discover the latest R&D trends, market data, and...

| Executive Summary


This peer-reviewed journal publication in Bioconjugate Chemistry shows how PEGylated lipid nanoparticles are used to deliver mRNA vaccines and other drugs, the immunogenicity concerns with vaccines,...

| Journal Publication